Skip to main content

Aspirean Wealth, LLC

13F filer · CIK 0002110285
Reported Aug 6, 2026
Net seller this quarter
13F portfolio value$108MU.S. long equity reported on 13F
Positions61 new · 0 closed
Net flow last quarter-$177KBuys minus sells
Top 10 positions weight21.5%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 6, 20266 positions
IDEVEndo Pharmaceuticals Solutions Inc.$16M14.85%Not reported-3.3%Q4 2025
QQQInvesco QQQ Trust, Series 1$3.23M3.00%Not reported+1.7%Q4 2025
BSVNBank7 Corp.$2.94M2.73%0.40%+1.2%Q4 2025
BRK.BBerkshire Hathaway Inc$548K0.51%Not reportedNot reportedQ4 2025
AISAntares Pharma, Inc.$270K0.25%Not reportedNewQ2 2026
IBITiShares Bitcoin Trust ETF$208K0.19%0.00%+7.8%Q4 2025
Q1 2026Reported May 14, 20265 positions
IDEVEndo Pharmaceuticals Solutions Inc.$15.5M16.84%Not reported-0.8%Q4 2025
BSVNBank7 Corp.$2.92M3.17%0.39%-0.2%Q4 2025
QQQInvesco QQQ Trust, Series 1$2.49M2.70%Not reported-10.0%Q4 2025
BRK.BBerkshire Hathaway Inc$525K0.57%Not reported+0.6%Q4 2025
IBITiShares Bitcoin Trust ETF$223K0.24%0.00%-8.0%Q4 2025
Q4 2025Reported Feb 17, 20265 positions
IDEVEndo Pharmaceuticals Solutions Inc.$15.4M16.85%Not reportedNewQ4 2025
QQQInvesco QQQ Trust, Series 1$2.94M3.22%Not reportedNewQ4 2025
BSVNBank7 Corp.$2.94M3.21%0.39%NewQ4 2025
BRK.BBerkshire Hathaway Inc$547K0.60%Not reportedNewQ4 2025
IBITiShares Bitcoin Trust ETF$313K0.34%0.00%NewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.